Cabozantinib Promising for Advanced Adrenocortical Carcinoma

FRIDAY, April 26, 2024-- For patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy, according to a study published online April 9 in The Lancet Oncology.Matthew T. Campbell, M.D., from The University of Texas MD...